Low-income, less educated don’t have same access to preventive treatments, researchers report By Robert Preidt THURSDAY, July 18 (HealthDay News) — Americans with low incomes and education levels are less likely to get eye care, a new study finds. Researchers examined data from nearly 3,600 people, aged 40 and older, who took part in the [Read More]
News
Gene Therapy Without Retinal Risk
Researchers have developed a method of delivering genes to the inner layers of the retina without the risks associated with injection into the delicate tissues themselves. This less invasive technique has been carried out successfully in animal models by a research team led by Drs. John G. Flannery and David V. Schaffer at the University [Read More]
Gene Expression in the Retina Expanded
Identifying the genetics of retinal degeneration has become especially important with progress of trials in gene therapy. Investigators have identified more than 200 retinal degeneration disease genes, but still haven’t been able to find the cause of disease in up to half of cases. Now Ocular Genomics Institute has announced that Drs. Michael Farkas, Eric [Read More]
Understand Drug Side Effects and Adverse Events
In the shadow of recent severe health problems caused by irresponsible repackaging (compounding) of drugs for use in the clinics, MD Support offers a free audio/visual presentation to help patients understand drug side effects and adverse events. Speaking to the International Low Vision Support Group, Dan Roberts addresses the compounding issue as part of a [Read More]
Visual Field Grid
The Visual Field Grid was designed to allow you to map the scotomas (blind spots) in your central vision. It is easy to do, and it can be used to either monitor your own own progress or to explain your vision to others. To map your visual field, print this page and follow the steps [Read More]